CDMO extends spray drying capacity for aqueous and organic solvent-based formulations
Micro-Sphere adds GEA PSD-3 spray dryer in response to increased demand in spray drying.
CDMO, Micro-Sphere has added to its decades of GMP spray drying services with the addition of new spray drying technology.
A dedicated production area houses a GEA PSD-3 spray dryer, which will extend the CDMO’s spray drying capacity for both aqueous and organic solvent-based formulations.
The new equipment is part of the CDMO’s recently announced 21 million CHF (€19 million) investment into expanding its GMP manufacturing capabilities at its facility in Switzerland and comes in response to increased demand for spray drying from companies ranging from Big Pharma to small virtual firms.
Micro-Sphere Founder and President of the Board, Dr Michele Müller, said: “Customer demand for GMP spray drying is increasing and this latest investment strengthens our production capabilities while also reaffirming our niche expertise in the market.
“The market response to our investment in our facility in Switzerland has been excellent and we are now implementing the upgrades and changes needed to offer greater capacity to handle larger quantities of pharmaceutical powders and commercial volumes of finished dosage forms.”
GEA’s technology for Spray Drying is based near Copenhagen in Denmark, where GEA develops and manufactures spray drying systems and has comprehensive test facilities for pharmaceutical customers.
Søren Terp Madsen, Product Manager at GEA added: “This new unit is equipped with the best available solutions in terms of spraying systems and cyclone for powder recovery: it offers excellent process reliability and is a great choice for Micro-Sphere in line with its continued expansion. We’re delighted to be a part of their exciting future.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance